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Abstract
Epidemiologic studies suggest that dietary vitamin E is a candidate intervention for atopic disease.
We used in vitro and ex vivo exposures to test the hypothesis that the most common dietary
isoform of vitamin E, γ-tocopherol (γT), could suppress FcεRI-mediated basophil activation.
Rat Basophilic Leukemia (RBL)-SX38 cells that express human FcεRI were treated with or
without γT, followed by stimulation with α-IgE. In the ex vivo study, 20 Der f 1-allergic
volunteers consumed a γT-enriched supplement for 7 days. Their basophils were challenged ex
vivo with α-IgE and graded doses of Der f 1 before and after the supplementation period.
γT treatment of RBL-SX38 cells significantly reduced basophil degranulation and de novo TH2
cytokine production. Daily consumption of a γT - rich supplement by dust mite-allergic
volunteers reduced basophil activation after ex vivo dust mite challenge.
Vitamin E supplements rich in γT may be useful adjuncts in decreasing atopic disease.
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Complementary and Alternative Medicine therapies have become increasingly popular in
the United States and Europe for the treatment of allergies and asthma 12. Vitamin E is a
nutritional antioxidant which has been studied for its impact in asthma. Decreased levels of
IgE and reduced occurrence of childhood asthma have been associated with intake of dietary
vitamin E (predominantly gamma tocopherol, γT) early in life 3 or in children of women
with high vitamin E intakes during pregnancy 4. In a rodent model of allergic rhinitis and
asthma, we found that daily administration of γT prior to Ova challenge depressed
eosinophil infiltration into the airways, as well as production of nasal TH2 cytokines and
pulmonary eicosanoids 5.
Previous work showed that vitamin E interfered with phosphoinositide-3-kinase and protein
kinase C activation 6, required for IgE-mediated degranulation and cytokine production by
mast cells and basophils. As an initial step in exploring the utility of γT as an adjunctive
treatment for atopy, we assessed the effect of γT in vitro on IgE-mediated degranulation and
mediator production using a rat basophilic leukemia cell line, RBL SX-38, which stably
expresses human FcεRI αβγ2. Based on promising in vitro findings, we then examined the
role of consuming a γT-enriched preparation on IgE-mediated basophil activation in a
proof-of-concept ex vivo study in dust mite allergic volunteers.
RBL SX-38 cells were kindly provided by Jean-Pierre Kinet from the Beth Israel Deaconess
Medical Center 7. The release assay was adapted from Blanc et al 8. Cells were sensitized
with 0.5 μg/ml human IgE (Abbiotec) or fresh media (MEM with 10% FBS from Hyclone)
for 24 hours. The next day, 20 uM γT, vehicle (0.1% DMSO), or 1 μM cyclosporine were
added and incubated for 16 hours overnight. The following morning, cells were washed with
NaPIPES buffer followed by stimulation with 10 μg/ml anti-human IgE antibody (α-IgE,
Bethyl Labs) for 60 minutes 7. All conditions were run in triplicate. Degranulation was
assessed by β-hexosaminidase release 7; total cellular β-hexosaminidase content was
quantified by lysing the cells with 0.1% Triton X-100. Supernatants were assayed in
duplicate for IL-4, IL-13, and CysLTs using the Luminex 100IS Multiplex flow cytometric
assay. Student's T tests were used to compare γT-treated cells to the vehicle control.
Pretreatment with 20 μM γT modestly but significantly inhibited α-IgE-stimulated β-
hexosaminidase release (Figure 1a, p=0.03). Although there was a significant reduction in
IL-4 & IL-13 production (p<0.01 for both) (Figure 1b-c) compared to the vehicle control,
there was a non-significant reduction in CysLT production (Figure 1d, p=0.06). γT
treatment did not induce cellular cytotoxicity compared to the culture media or to the vehicle
control (data not shown), assessed by a LDH cytotoxicity assay (Cayman Chemicals).
The ex vivo study was reviewed and approved by the Committee for the Protection of the
Rights of Human subjects of the University of North Carolina, and registered on
ClinicalTrials.gov (NCT00836368). Twenty D. farinae-allergic volunteers (ages 18-50)
completed the study. The primary endpoint was %CD63high basophils as a marker of
basophil activation 9 after ex vivo challenge with Der f 1, using paired testing to compare the
post supplementation values to baseline values.
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Each subject took 2 capsules of a γT-enriched supplement on a daily basis for 7 days
provided by YASOO Health Inc. (Johnson City, TN). Each γT-enriched capsule contained
50 mg d-α-tocopherol, 240 mg d-β tocopherol plus d-δ-tocopherol, and 540 mg d-γ
tocopherol 10. Blood was drawn immediately before the first supplementation dose, and six
hours after the day 7 dose. Whole blood was primed with 2 ng/ml of human rIL-3 for 10
minutes. Samples were then incubated with PBS, 10 μg/ml α-IgE or Der f 1 (Greer
Laboratories, Lenoir, NC) (0.1, 1, and 10 μg/ml) for 30 minutes at 37C and then placed on
ice.
The percentages of CD63high and CD203chigh cells served as indices of basophil
activation 9. Expression of CD63/LAMP-3 and CD203c/E-NNP3 on circulating basophils
were measured by flow cytometry (BD-LSR-II flow cytometer and BD FACSDiva 6.1
software). Basophils were identified in blood as CD203c(+) cells with low side scatter
within the CD45(+) leukocyte population. Using histogram analysis, ≈98 to 99% (minimum
95%) of the basophil population of the un-stimulated controls was gated to establish the
baseline expression (mean fluorescent intensity) of each of the surface proteins. Basophils
which shifted to the right out of the baseline gate (CD63high and CD203chigh) following
stimulation with α-IgE or Der f 1 were considered activated. Flow cytometric values were
corrected for mechanical manipulation of cells by subtracting the PBS control values from
the α-IgE and Der f 1 values. Basophil activation was compared before and after 7 days of
supplementation using Wilcoxon signed rank tests.
α-IgE and Der f 1 (0.1, 1, and 10 μg/ml) all significantly upregulated CD63 & CD203c on
basophils compared to the PBS control (p<0.001 for all comparisons). After one week of
γT-enriched supplementation, %CD203chigh basophils were significantly decreased with α-
IgE and all doses of Der f 1 (p<0.01, Figure 2a); %CD63high basophils were significantly
decreased with α-IgE and the 0.1 μg/ml Der f 1 dose (Figure 2b).
We conducted these studies to determine if γT may be a useful adjunct therapy against IgE-
mediated processes. Results of in vitro studies suggested IgE-mediated basophil activation
& de novo mediator production is modestly reduced with a γT concentration similar to that
observed in the serum of healthy and atopic volunteers after oral supplementation with the
identical γT dosing regimen 1011. Although supplementation with α-tocopherol was
previously noted to increase bleeding risk 12, this side effect has not been noted with γT
supplementation. We demonstrated that oral consumption of the γT-enriched supplement by
dust mite-allergic volunteers reduced ex vivo IgE-mediated upregulation of CD63 &
CD203c, suggestive of reduced basophil activation 9. This open label proof-of-concept study
provides rationale for further mechanistic work examining the inhibitory effect of γT on
IgE-mediated activation, as well as for placebo controlled phase II studies to assess the
safety and clinical impact of γT supplementation as a therapeutic intervention for allergic
asthma & rhinitis.
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Figure 1. Effect of γT on degranulation, de novo TH2 cytokines, and cysteinyl leukotrienes in a
basophil cell line
(A). % basophil degranulation (compared to total cellular content of β-hexosaminidase) with
culture media & with pretreatment with vehicle control, 20 μM γT, or 1 μM cyclosporine
(CSA) prior to stimulation with human α-IgE. De-novo production of IL-4 (B), IL-13 (C),
and CysLTs (D) after stimulation of RBL SX-38 cells with human α-IgE. Mean and SEM
are shown.
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Figure 2. Effect of oral γT supplementation on basophil activation with dust mite allergen in 20
Der f 1-allergic volunteers
Volunteers had positive skin prick testing to D. farinae (defined as a 3 mm wheal greater
than the negative saline control), and mean Der f 1 IgE of 15.8 (SD + 21.5) IU/ml.
%CD203chigh basophils (A) and %CD63high basophils (B) with α–IgE and graded doses of
Der f 1. Mean and SEM are shown.
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